Investments, Legislation, Lithuania, Markets and Companies, Medicine
International Internet Magazine. Baltic States news & analytics
Tuesday, 08.07.2025, 07:07
Sanitas receives notification on mandatory tender offer
Danuta Pavilenene, BC, Vilnius, 21.09.2011.
Print version

The Lithuania-based pharmacy producer Sanitas received a report from its shareholder Valeant Pharmaceuticals International, Inc. on September 20, 2011, on the implementation of the mandatory non-competitive tender offer, the company said in a report.
![]() |
---|
During the implementation period, Valeant Pharmaceuticals International bought 1,968,631 ordinary registered shares of Sanitas with nominal value amounting to one litas each.
That number represents 6.33% of voting rights at the general meeting of shareholders of the company, writes LETA/ELTA.
As reported, consolidated pre-audited profit before tax of Sanitas and its enterprises in the first half of 2011 amounted to 12.7 million litas.
In the same period Sanitas Group's profit before tax amounted to 20.1 million litas.
The group's sales in the first half amounted to 170 million litas, while in the same period of 2010 it amounted to 177 million litas.